117 related articles for article (PubMed ID: 17605393)
41. [Thrombolytic therapy after intraventricular haemorrhage].
Gadegaard KH; Dahl BL; Hansen TS
Ugeskr Laeger; 2010 May; 172(19):1440-1. PubMed ID: 20470653
[TBL] [Abstract][Full Text] [Related]
42. Efficacy and safety of flow-directed pulmonary artery catheter thrombolysis for treatment of submassive pulmonary embolism.
Gaba RC; Gundavaram MS; Parvinian A; Knuttinen MG; Minocha J; Owens CA; Bui JT
AJR Am J Roentgenol; 2014 Jun; 202(6):1355-60. PubMed ID: 24848835
[TBL] [Abstract][Full Text] [Related]
43. [Local intra-arterial thrombolysis in acute ischemia of an extremity].
Enevoldsen MT; Rørdam P; Schroeder TV
Ugeskr Laeger; 1996 Sep; 158(36):5011-4. PubMed ID: 8928238
[TBL] [Abstract][Full Text] [Related]
44. In vitro sonothrombolysis of human blood clots with BR38 microbubbles.
Petit B; Gaud E; Colevret D; Arditi M; Yan F; Tranquart F; Allémann E
Ultrasound Med Biol; 2012 Jul; 38(7):1222-33. PubMed ID: 22542261
[TBL] [Abstract][Full Text] [Related]
45. Bioconjugation of recombinant tissue plasminogen activator to magnetic nanocarriers for targeted thrombolysis.
Yang HW; Hua MY; Lin KJ; Wey SP; Tsai RY; Wu SY; Lu YC; Liu HL; Wu T; Ma YH
Int J Nanomedicine; 2012; 7():5159-73. PubMed ID: 23055728
[TBL] [Abstract][Full Text] [Related]
46. Cavitational mechanisms in ultrasound-accelerated fibrinolysis.
Prokop AF; Soltani A; Roy RA
Ultrasound Med Biol; 2007 Jun; 33(6):924-33. PubMed ID: 17434661
[TBL] [Abstract][Full Text] [Related]
47. Flow-induced permeation of non-occlusive blood clots: an MRI study and modelling.
Grobelnik B; Vidmar J; Tratar G; Blinc A; Sersa I
Eur Biophys J; 2008 Sep; 37(7):1229-33. PubMed ID: 18478224
[TBL] [Abstract][Full Text] [Related]
48. Assessment of fibrinolytic activity by measuring the lysis time of a tissue-factor-induced clot: a feasibility evaluation.
Cellai AP; Lami D; Magi A; Liotta AA; Rogolino A; Antonucci E; Bandinelli B; Abbate R; Prisco D
Clin Appl Thromb Hemost; 2010 Jun; 16(3):337-44. PubMed ID: 19117964
[TBL] [Abstract][Full Text] [Related]
49. Recombinant human C1-inhibitor prevents non-specific proteolysis by mutant pro-urokinase during optimal fibrinolysis.
Gurewich V; Pannell R
Thromb Haemost; 2009 Aug; 102(2):279-86. PubMed ID: 19652878
[TBL] [Abstract][Full Text] [Related]
50. Pulse-spray pharmacomechanical thrombolysis of thrombosed hemodialysis access grafts: long-term experience and comparison of original and current techniques.
Valji K; Bookstein JJ; Roberts AC; Oglevie SB; Pittman C; O'Neill MP
AJR Am J Roentgenol; 1995 Jun; 164(6):1495-500; discussion 1501-3. PubMed ID: 7754901
[TBL] [Abstract][Full Text] [Related]
51. Reperfusion and outcomes in Penumbra vs. systemic tissue plasminogen activator clinical trials.
Alexandrov AV; Schellinger PD; Saqqur M; Barreto A; Demchuk AM; Ribo M; Rubiera M; Sharma VK; Heliopoulos I; Alexandrov AW; Molina CA; Tsivgoulis G;
Int J Stroke; 2011 Apr; 6(2):118-22. PubMed ID: 21371272
[TBL] [Abstract][Full Text] [Related]
52. Intra-arterial thrombolysis: tissue plasminogen activator and other thrombolytic agents.
Samaniego EA; Linfante I; Dabus G
Tech Vasc Interv Radiol; 2012 Mar; 15(1):41-6. PubMed ID: 22464301
[TBL] [Abstract][Full Text] [Related]
53. Thrombin activatable fibrinolysis inhibitor (TAFI) does not inhibit in vitro thrombolysis by pharmacological concentrations of t-PA.
Colucci M; D'Aprile AM; Italia A; Gresele P; Morser J; Semeraro N
Thromb Haemost; 2001 Apr; 85(4):661-6. PubMed ID: 11341502
[TBL] [Abstract][Full Text] [Related]
54. Cloning, purification and biochemical characterization of a thrombus-ditargeting thrombolytic agent, comprised of annexin B1, ScuPA-32K and fibrin-adherent peptide.
Ding FX; Yan HL; Lu YM; Xue G; Mei Q; Huang JJ; Zhao ZY; Wang YZ; Sun SH
J Biotechnol; 2006 Nov; 126(3):394-405. PubMed ID: 16797768
[TBL] [Abstract][Full Text] [Related]
55. Interactions between iodinated contrast media and tissue plasminogen activator: In vitro comparison study.
Vörös E; Deres L; Halmosi R; Várady E; Tóth K; Battyáni I
Clin Hemorheol Microcirc; 2017; 66(2):167-174. PubMed ID: 28372322
[TBL] [Abstract][Full Text] [Related]
56. [An experimental study of local fibrinolysis using tissue plasminogen activator and urokinase in a canine common carotid artery thrombus model].
Kawakami K; Takahashi A; Yoshimoto T
No To Shinkei; 1990 Feb; 42(2):193-201. PubMed ID: 2113401
[TBL] [Abstract][Full Text] [Related]
57. Differences in clot preparation determine outcome of recombinant tissue plasminogen activator treatment in experimental thromboembolic stroke.
Niessen F; Hilger T; Hoehn M; Hossmann KA
Stroke; 2003 Aug; 34(8):2019-24. PubMed ID: 12843350
[TBL] [Abstract][Full Text] [Related]
58. The platelet-rich plasma clot: a standardized in-vitro clot formation protocol for investigations of sonothrombolysis under physiological flows.
Roessler FC; Ohlrich M; Marxsen JH; Stellmacher F; Sprenger A; Dempfle CE; Seidel G
Blood Coagul Fibrinolysis; 2011 Jul; 22(5):407-15. PubMed ID: 21519235
[TBL] [Abstract][Full Text] [Related]
59. Therapeutic application of contrast-enhanced ultrasound and low-dose urokinase for thrombolysis in a porcine model of acute peripheral arterial occlusion.
Ebben HP; Nederhoed JH; Slikkerveer J; Kamp O; Tangelder GW; Musters RJ; Wisselink W; Yeung KK
J Vasc Surg; 2015 Aug; 62(2):477-85. PubMed ID: 24768365
[TBL] [Abstract][Full Text] [Related]
60. A multicenter, randomized, controlled study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits with Intra-Arterial therapy (EXTEND-IA).
Campbell BC; Mitchell PJ; Yan B; Parsons MW; Christensen S; Churilov L; Dowling RJ; Dewey H; Brooks M; Miteff F; Levi C; Krause M; Harrington TJ; Faulder KC; Steinfort BS; Kleinig T; Scroop R; Chryssidis S; Barber A; Hope A; Moriarty M; McGuinness B; Wong AA; Coulthard A; Wijeratne T; Lee A; Jannes J; Leyden J; Phan TG; Chong W; Holt ME; Chandra RV; Bladin CF; Badve M; Rice H; de Villiers L; Ma H; Desmond PM; Donnan GA; Davis SM;
Int J Stroke; 2014 Jan; 9(1):126-32. PubMed ID: 24207098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
